FR2885128B1 - Composition cosmetique a visee depigmentante ou eclaircissante comprenant au moins une oxazoline, a titre de principe actif depigmentant ou eclaircissant - Google Patents

Composition cosmetique a visee depigmentante ou eclaircissante comprenant au moins une oxazoline, a titre de principe actif depigmentant ou eclaircissant

Info

Publication number
FR2885128B1
FR2885128B1 FR0504227A FR0504227A FR2885128B1 FR 2885128 B1 FR2885128 B1 FR 2885128B1 FR 0504227 A FR0504227 A FR 0504227A FR 0504227 A FR0504227 A FR 0504227A FR 2885128 B1 FR2885128 B1 FR 2885128B1
Authority
FR
France
Prior art keywords
depigmenting
lightening
active ingredient
oxazoline
cosmetic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0504227A
Other languages
English (en)
French (fr)
Other versions
FR2885128A1 (fr
Inventor
Nathalie Piccardi
Philippe Msika
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Expanscience SA
Original Assignee
Laboratoires Expanscience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0504227A priority Critical patent/FR2885128B1/fr
Application filed by Laboratoires Expanscience SA filed Critical Laboratoires Expanscience SA
Priority to US11/919,253 priority patent/US8722023B2/en
Priority to ES06754908T priority patent/ES2322198T3/es
Priority to EP06754908A priority patent/EP1874410B1/fr
Priority to JP2008508231A priority patent/JP5010582B2/ja
Priority to CN2006800146098A priority patent/CN101198377B/zh
Priority to KR1020077025815A priority patent/KR101309569B1/ko
Priority to HK08107084.4A priority patent/HK1111924B/xx
Priority to DE602006005637T priority patent/DE602006005637D1/de
Priority to AT06754908T priority patent/ATE424896T1/de
Priority to PL06754908T priority patent/PL1874410T3/pl
Priority to MX2007013449A priority patent/MX2007013449A/es
Priority to PCT/EP2006/061902 priority patent/WO2006114443A1/fr
Publication of FR2885128A1 publication Critical patent/FR2885128A1/fr
Application granted granted Critical
Publication of FR2885128B1 publication Critical patent/FR2885128B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR0504227A 2005-04-27 2005-04-27 Composition cosmetique a visee depigmentante ou eclaircissante comprenant au moins une oxazoline, a titre de principe actif depigmentant ou eclaircissant Expired - Lifetime FR2885128B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR0504227A FR2885128B1 (fr) 2005-04-27 2005-04-27 Composition cosmetique a visee depigmentante ou eclaircissante comprenant au moins une oxazoline, a titre de principe actif depigmentant ou eclaircissant
PL06754908T PL1874410T3 (pl) 2005-04-27 2006-04-27 Odbarwiająca lub rozjaśniająca kompozycja kosmetyczna zawierająca co najmniej jedną oksazolinę jako składnik aktywny
EP06754908A EP1874410B1 (fr) 2005-04-27 2006-04-27 Composition cosmetique depigmentante ou eclaircissante comprenant au moins une oxazoline a titre de principe actif
JP2008508231A JP5010582B2 (ja) 2005-04-27 2006-04-27 少なくとも一のオキサゾリンを活性成分として含有する、色素消失用又は光沢化粧品組成物
CN2006800146098A CN101198377B (zh) 2005-04-27 2006-04-27 含有至少一种噁唑啉作为活性组分的祛斑或美白用美容组合物
KR1020077025815A KR101309569B1 (ko) 2005-04-27 2006-04-27 활성 성분으로 적어도 하나의 옥사졸린을 포함하는 탈색또는 미백 화장료 조성물
US11/919,253 US8722023B2 (en) 2005-04-27 2006-04-27 Depigmenting or brigthening cosmetic composition comprising at least one oxazolin as an active ingredient
DE602006005637T DE602006005637D1 (de) 2005-04-27 2006-04-27 Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst
AT06754908T ATE424896T1 (de) 2005-04-27 2006-04-27 Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst
ES06754908T ES2322198T3 (es) 2005-04-27 2006-04-27 Composicion cosmetica despigmentante o aclarante que comprende por lo menos una oxazolina a titulo de principio activo.
MX2007013449A MX2007013449A (es) 2005-04-27 2006-04-27 Composicion cosmetica para despigmentacion o aclaracion que comprende al menos una oxazolina como un ingrediente activo.
PCT/EP2006/061902 WO2006114443A1 (fr) 2005-04-27 2006-04-27 Composition cosmetique depigmentante ou eclaircissante comprenant au moins une oxazoline a titre de principe actif
HK08107084.4A HK1111924B (en) 2005-04-27 2006-04-27 Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504227A FR2885128B1 (fr) 2005-04-27 2005-04-27 Composition cosmetique a visee depigmentante ou eclaircissante comprenant au moins une oxazoline, a titre de principe actif depigmentant ou eclaircissant

Publications (2)

Publication Number Publication Date
FR2885128A1 FR2885128A1 (fr) 2006-11-03
FR2885128B1 true FR2885128B1 (fr) 2007-07-06

Family

ID=35478674

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0504227A Expired - Lifetime FR2885128B1 (fr) 2005-04-27 2005-04-27 Composition cosmetique a visee depigmentante ou eclaircissante comprenant au moins une oxazoline, a titre de principe actif depigmentant ou eclaircissant

Country Status (12)

Country Link
US (1) US8722023B2 (enExample)
EP (1) EP1874410B1 (enExample)
JP (1) JP5010582B2 (enExample)
KR (1) KR101309569B1 (enExample)
CN (1) CN101198377B (enExample)
AT (1) ATE424896T1 (enExample)
DE (1) DE602006005637D1 (enExample)
ES (1) ES2322198T3 (enExample)
FR (1) FR2885128B1 (enExample)
MX (1) MX2007013449A (enExample)
PL (1) PL1874410T3 (enExample)
WO (1) WO2006114443A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2251001A4 (en) * 2008-02-08 2013-01-09 Shiseido Co Ltd SKIN BLEACHING AND EXTERNAL PREPARATION FOR THE SKIN
AU2012327209B2 (en) * 2012-02-17 2016-05-19 Epitech Group S.P.A. Compositions and methods for the modulation of specific amidases for N-acylethanolamines for use in the therapy of inflammatory diseases
FR3098405B1 (fr) 2019-07-12 2021-06-25 Expanscience Lab Composition comprenant des polyphénols de graines de passiflore, des peptides d’avocat et un extrait d’hamamélis et utilisation pour traiter et/ou prévenir les vergetures
FR3098394B1 (fr) 2019-07-12 2022-07-08 Expanscience Lab Composition comprenant au moins une oxazoline pour inhiber la croissance de levure du genre Malassezia impliquée notamment dans les croûtes de lait
FR3167553A1 (fr) 2024-10-18 2026-04-24 Laboratoire Sanoflore Composition a base de pissenlit pour prévenir et réduire les tâches

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6281011A (ja) * 1985-10-04 1987-04-14 Komatsu Ltd 比例ソレノイドの制御装置
US5686489A (en) * 1986-12-23 1997-11-11 Tristrata Technology, Inc. Alpha hydroxyacid esters for skin aging
US4876249A (en) 1987-01-12 1989-10-24 Rajadhyaksha Vithal J Compositions and method comprising heterocyclic compounds containing two heteroatoms
JP2506384B2 (ja) * 1987-09-25 1996-06-12 三省製薬株式会社 外用剤
US6750229B2 (en) * 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
FR2834216B1 (fr) * 2001-12-27 2004-04-30 Pharmascience Lab Composition cosmetique ou pharmaceutique comprenant au moins une oxazoline pour inhiber la migration des cellules de langerhans, et ses utilisations
FR2856294B1 (fr) 2003-06-18 2005-08-05 Expanscience Lab Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
FR2934216B1 (fr) 2008-07-22 2018-10-26 Renault Sas Procede de freinage a recuperation d'energie pour un vehicule automobile

Also Published As

Publication number Publication date
CN101198377A (zh) 2008-06-11
JP5010582B2 (ja) 2012-08-29
JP2008539206A (ja) 2008-11-13
EP1874410B1 (fr) 2009-03-11
ATE424896T1 (de) 2009-03-15
ES2322198T3 (es) 2009-06-17
PL1874410T3 (pl) 2009-07-31
KR101309569B1 (ko) 2013-09-17
CN101198377B (zh) 2011-01-05
HK1111924A1 (zh) 2008-08-22
US8722023B2 (en) 2014-05-13
EP1874410A1 (fr) 2008-01-09
KR20080000641A (ko) 2008-01-02
FR2885128A1 (fr) 2006-11-03
MX2007013449A (es) 2008-01-21
US20090274637A1 (en) 2009-11-05
DE602006005637D1 (de) 2009-04-23
WO2006114443A1 (fr) 2006-11-02

Similar Documents

Publication Publication Date Title
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
MY143795A (en) Tetrahydropyridoindole derivatives
WO2007093624A3 (en) Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin
CL2007002095A1 (es) Composicion farmaceutica topica que comprende 1-(2-metilpropil)-1h-imidazo[4,5-c]quinolin-4-amina; composicion empacada; metodo para esterilizarla; util para cicatrizar tejido donde la dermis se ha desgarrado.
WO2006138418A3 (en) Improvement of cognitive performance with sirtuin activators
FR2927254B1 (fr) Utilisation de substances actives naturelles dans des compositions cosmetiques ou therapeutiques
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
TW200637522A (en) Skin treatment articles and methods
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
WO2006096439A3 (en) Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
FR2856294B1 (fr) Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
IL192103A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
UA90467C2 (ru) Применение пептидных соединений для лечения боли при болезненой диабетической невропатии
ATE537828T1 (de) Psychotropes mittel und nahrungsmittel zur förderung der gesundheit enthaltend neferin
TW200611695A (en) Pyrrolopyridine derivatives
MX2007006539A (es) Sistema para la absorcion percutanea mejorada de los agentes beneficiadores de la piel.
CL2009001267A1 (es) Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.
ATE437679T1 (de) Wässrige antitranspirant formulierung
WO2007025994A3 (fr) Utilisation d'au moins un 2-alkyle furane, a titre de principe actif depigmentant ou eclaircissant
ATE424896T1 (de) Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst
SE0203817D0 (sv) New composition
WO2008080682A3 (de) Synergistische kombination von seidenproteinen und ausgewählten metallen
ATE287716T1 (de) Metallsalze als antimykotika

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20